Puma Biotechnology | PBYI - Attività Correnti





Attività Correnti Cambiamento Data
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 31.48B 2.42B 2026-03
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Exelixis USD 1.21B 234.65M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Incyte USD 6.03B 542.31M 2026-06
MacroGenics USD 182.52M 37.42M 2026-03
Moderna USD 5.82B 45M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Takeda JPY 3.15T 59.77B 2026-06
TG Therapeutics USD 1.09B 456.2M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03